Evaluating the Efficacy and Feasibility of a Novel Wireless ECG Recording System in Monitoring Patients After Atrial Fibrillation Ablation Procedure
Completed
- Conditions
- Persistent Atrial FibrillationParoxysmal Atrial Fibrillation
- Registration Number
- NCT01912911
- Lead Sponsor
- The Cleveland Clinic
- Brief Summary
The investigators goal in this study is to examine the feasibility and efficacy of AliveCor iphone case monitoring device in monitoring patients after AF ablation by comparing transmissions using Alive Cor with transmissions from a traditional transtelephonic monitor (TTM).
A secondary goal is to assess the ease of use of AliveCor device compared to traditional TTM system from the patient's perspective
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- Male or female between > 18 and < 75 years of age
- Paroxysmal or persistent atrial fibrillation
- Scheduled to undergo an AF ablation procedure
- Already has iPhone 4 or iPhone 4S with data plan
- Willing to use the iPhone Alive Cor case
- Written informed consent
Exclusion Criteria
- Unable or unwilling to use the Alive Cor case for their iPhone or iPhone 4S
- Residing outside the United States
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of AF/flutter events detected by the AliveCor device will be compared to events detected by the TTM for each episode. 3 months
- Secondary Outcome Measures
Name Time Method Amount of transmissions from smartphone in comparison with traditional TTM method 3 months
Trial Locations
- Locations (1)
Cleveland Clinic HVI
🇺🇸Cleveland, Ohio, United States